Krystyna Ossowska

2.9k total citations
109 papers, 2.4k citations indexed

About

Krystyna Ossowska is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Krystyna Ossowska has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cellular and Molecular Neuroscience, 50 papers in Neurology and 32 papers in Molecular Biology. Recurrent topics in Krystyna Ossowska's work include Neuroscience and Neuropharmacology Research (67 papers), Neurological disorders and treatments (38 papers) and Parkinson's Disease Mechanisms and Treatments (32 papers). Krystyna Ossowska is often cited by papers focused on Neuroscience and Neuropharmacology Research (67 papers), Neurological disorders and treatments (38 papers) and Parkinson's Disease Mechanisms and Treatments (32 papers). Krystyna Ossowska collaborates with scholars based in Poland, Germany and Czechia. Krystyna Ossowska's co-authors include S. Wolfarth, Jadwiga Wardas, Stanisław Wolfarth, Jolanta Konieczny, Katarzyna Kuter, Andrzej Pilc, M. Pietraszek, Elżbieta Lorenc‐Koci, G. Schulze and Joanna M. Wierońska and has published in prestigious journals such as PLoS ONE, Brain Research and Neuroscience.

In The Last Decade

Krystyna Ossowska

108 papers receiving 2.3k citations

Peers

Countries citing papers authored by Krystyna Ossowska

Since Specialization

Citations

This map shows the geographic impact of Krystyna Ossowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystyna Ossowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystyna Ossowska more than expected).

Fields of papers citing papers by Krystyna Ossowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krystyna Ossowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystyna Ossowska. The network helps show where Krystyna Ossowska may publish in the future.

Co-authorship network of co-authors of Krystyna Ossowska

This figure shows the co-authorship network connecting the top 25 collaborators of Krystyna Ossowska. A scholar is included among the top collaborators of Krystyna Ossowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystyna Ossowska. Krystyna Ossowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Zona incerta as a therapeutic target in Parkinson’s disease 2019 ·Journal of Neurology ·Krystyna Ossowska	52
2	Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Katarzyna Kuter, (unknown), (unknown), Urszula Głowacka, Michiru D. Sugawa, Krystyna Ossowska, Norbert A. Dencher	41
3	Apomorphine enhances harmaline-induced tremor in rats 2014 ·Pharmacological Reports ·Krystyna Ossowska, Urszula Głowacka, (unknown), Jadwiga Wardas	14
4	Increased Reactive Oxygen Species Production in the Brain After Repeated Low-Dose Pesticide Paraquat Exposure in Rats. A Comparison with Peripheral Tissues 2010 ·Neurochemical Research ·Katarzyna Kuter, Przemysław Nowak, Krystyna Gołembiowska, Krystyna Ossowska	37
5	9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease 2010 ·Pharmacological Reports ·Catrin Wernicke, (unknown), Barbara A. Zieba, Katarzyna Kuter, Krystyna Ossowska, Monika Frenzel, Norbert A. Dencher, Hans Rommelspacher	43
6	Parkinson??s disease-like syndrome in rats induced by 2,9-dimethyl-??-carbolinium ion, a ??-carboline occurring in the human brain 2006 ·Behavioural Pharmacology ·Elżbieta Lorenc‐Koci, Hans Rommelspacher, G. Schulze, Catrin Wernicke, Katarzyna Kuter, (unknown), (unknown), (unknown), Krystyna Ossowska	13
7	MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats 2005 ·Neuropharmacology ·Krystyna Ossowska, Jolanta Konieczny, S. Wolfarth, Andrzej Pilc	42
8	The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors 2002 ·Brain Research ·Krystyna Ossowska, Jolanta Konieczny, Andrzej Pilc, Stanisław Wolfarth	10
9	The role of glutamate receptors in antipsychotic drug action 2000 ·Amino Acids ·Krystyna Ossowska, M. Pietraszek, Jadwiga Wardas, Gabriel Nowak, Wojciech M. Zajączkowski, S. Wolfarth, Andrzej Pilc	35
10	L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats 1999 ·Psychopharmacology ·Jolanta Konieczny, Krystyna Ossowska, G. Schulze, H. Coper, Stanisław Wolfarth	18
11	Age-related muscle stiffness: predominance of non-reflex factors 1997 ·Neuroscience ·S. Wolfarth, Elżbieta Lorenc‐Koci, G. Schulze, Krystyna Ossowska, Anna Kamińska, H. Coper	15
12	Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements 1996 ·Neuroscience ·S. Wolfarth, Jolanta Konieczny, Maria Śmiałowska, G. Schulze, Krystyna Ossowska	32
13	The subsensitivity of striatal glytamate receptors induced by chronic haloperidol in rats 1995 ·Acta Neurobiologiae Experimentalis ·Krystyna Ossowska	1
14	Stimulation of glutamate receptors in the intermediate/caudal striatum induces contralateral turning 1995 ·European Journal of Pharmacology ·Krystyna Ossowska, Stanisław Wolfarth	29
15	Does reserpine induce parkinsonian rigidity? 1995 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Elżbieta Lorenc‐Koci, Krystyna Ossowska, Jadwiga Wardas, S. Wolfarth	30
16	The subsensitivity of striatal glutamate receptors induced by chronic haloperidol in rats 1995 ·European Journal of Pharmacology ·Krystyna Ossowska	8
17	Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: A mechanomyographic analysis 1994 ·Journal of Neural Transmission - Parkinsons Disease and Dementia Section ·Krystyna Ossowska, Elżbieta Lorenc‐Koci, S. Wolfarth	25
18	MUSCLE WEAKNESS AND CONTINUOUS EMG ACTIVITY IN SENILE RATS; AN ANIMAL MODEL OF SPASTICITY? 1992 ·Behavioural Pharmacology ·S. Wolfarth, G. Schulze, Krystyna Ossowska, (unknown), I Hausmanowa-Pétrusewicz, H. Coper	2
19	Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia? 1989 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Stanisław Wolfarth, Krystyna Ossowska	41
20	The neostriatal inhibition of catalepsy, but not of muscle rigidity, evoked from the substantia nigra pars reticulata 1987 ·Pharmacology Biochemistry and Behavior ·Wacław Kolasiewicz, A.R. Cools, Krystyna Ossowska, S. Wolfarth	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact